Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012522 |
---|---|
Receipt number | R000014557 |
Scientific Title | Efficacy and Safety of Cytokines Versus Sunitinib as First-line Followed by Second-line Axitinib in the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Phase III Randomized Sequential Open-Label Study |
Date of disclosure of the study information | 2013/12/09 |
Last modified on | 2023/01/16 13:12:45 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/12/09 00:58:38 | ||
2 | Update | 2013/12/15 12:51:54 | Key inclusion criteria |
|
3 | Update | 2023/01/16 13:12:45 | Recruitment status Date of IRB Last follow-up date |